| Name | Title | Contact Details |
|---|---|---|
Dave Fitzgerald |
General Counsel | Profile |
Origence is a company that provides end-to-end lending solutions for consumers and lenders, from application to closing, with a focus on innovation, efficiency, and better experiences.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Well Data Labs offers a modern way to manage, analyze & report frac data. We work with industry experts to empower engineers to help them get jobs done.
MapArt MAPmedia is a Etobicoke, ON-based company in the Software & Internet sector.